Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “POST LIVER TRANSPLANT”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT00582738
What this trial is testing

Efficacy of Everolimus as Inhibitor of Fibrosis Progression in Liver Transplant Patients With Recurrence of Hepatitis C Viral Infection

Who this might be right for
Recurrent Hepatitis C
Novartis Pharmaceuticals 43
Not applicableStudy completedNCT05514743
What this trial is testing

Response of Cardiovascular Parameters to Physical Therapy Post Liver Transplantation

Who this might be right for
Liver Transplant; Complications
General Committee of Teaching Hospitals and Institutes, Egypt 30
Not applicableStudy completedNCT03238443
What this trial is testing

Interest of the Donor-specific Antibodies After Liver Transplantation

Who this might be right for
Liver Transplant
University Hospital, Lille 120
Not applicableStudy completedNCT01590615
What this trial is testing

Registry Study for Patients With Chronic HBV Receiving Nucleotide Therapy

Who this might be right for
Hepatitis B
Gilead Sciences 54
Not applicableStudy completedNCT05202184
What this trial is testing

Non Transplantable Recurrence After Percutaneous Thermal Ablation of HCC

Who this might be right for
HCC
University Hospital, Montpellier 213
Large-scale testing (Phase 3)Study completedNCT00328770
What this trial is testing

De Novo Sirolimus-based Immunosuppression After Liver Transplantation for Hepatocellular Carcinoma

Who this might be right for
Liver Carcinoma
University of Alberta 70
Large-scale testing (Phase 3)Study completedNCT01046799
What this trial is testing

Prevention of Hepatitis B Virus Reinfection After Liver Transplantation With Entecavir

Who this might be right for
Liver TransplantationHepatitis BLiver Disease
HepNet Study House, German Liverfoundation 20
Not applicableUnknownNCT03839706
What this trial is testing

Relationship Between 18FDG PET/MRI Patterns and ctDNA to Predict HCC Recurrence After Liver Transplantation

Who this might be right for
Hepatocellular Carcinoma
University Health Network, Toronto 20
Not applicableStudy completedNCT01444079
What this trial is testing

Graft Rejection or Tolerance Affected by Serial Change of Anti-donor Lymphocyte Antibody After Liver Transplantation

Who this might be right for
Liver Transplant Rejection
Yonsei University 48
Post-approval studies (Phase 4)Study completedNCT03423225
What this trial is testing

To Evaluate the Efficacy and Safety of ADVAGRAF® After Treatment With a Tacrolimus in New Liver Transplant Recipients

Who this might be right for
Liver Transplantation
Kim, Seoung-Hoon 31
Not applicableStudy completedNCT06799468
What this trial is testing

Validation of the TRAIN-AI for the Risk of HCC Recurrence After Liver Transplantation

Who this might be right for
Hepatocellular Carcinoma (HCC)Liver TransplantationDeep Learning Model
European Hepatocellular Cancer Liver Transplant Group 1,769
Not applicableUnknownNCT03603548
What this trial is testing

Comparison of Safety and Efficacy of Two Variants of Prolonged - Released Tacrolimus (Advagraf vs. Envarsus ) in Patients After Liver Transplantation : Single Center Randomised Control Trial

Who this might be right for
Liver Transplant RejectionImmunosuppression
Medical University of Warsaw 200
Not applicableStudy completedNCT01429155
What this trial is testing

Outcomes in Hepatitis C After Living Donor Liver Transplantation in Association With Interleukin 28 B

Who this might be right for
Hepatitis C
Henry Ford Health System 36
Not applicableUnknownNCT02851550
What this trial is testing

Assessement of the Prevalence of Lysosomal Acid Lipase Deficiency in Liver Post-transplant Patients

Who this might be right for
Liver Post-transplant Patients
Hospices Civils de Lyon 100
Early research (Phase 1)UnknownNCT02399735
What this trial is testing

Safety Study of NK Cells From Sibship to Treat the Recurrence of HCC After Liver Transplantation

Who this might be right for
Hepatocellular Carcinoma
Third Affiliated Hospital, Sun Yat-Sen University 18
Not applicableStudy completedNCT03130608
What this trial is testing

Inspiratory Muscle Training Post-Liver Transplant

Who this might be right for
Liver Disease ChronicMuscle WeaknessRespiratory Insufficiency
University of Miami 37
Not applicableStudy completedNCT02307890
What this trial is testing

The Relationship of Initial Liver Profile and Outcome After Transplantation

Who this might be right for
Liver Failure
University of Edinburgh 100
Large-scale testing (Phase 3)UnknownNCT04237740
What this trial is testing

Relenvatinib in the Tatment of Recurrence of Hepatocellular Carcinoma After Liver Transplantation

Who this might be right for
Hepatocellular CarcinomaLiver Transplantation
RenJi Hospital 40
Not applicableStudy completedNCT06606184
What this trial is testing

Benefits of Pulmonary Rehabilitation to Patients Post Liver Transplant

Who this might be right for
Liver Transplant Surgery
Chang Gung University 78
Not applicableStudy completedNCT07066384
What this trial is testing

Comparison of Breathing Yoga and Progressive Muscle Relaxation Techniques After Transplantation

Who this might be right for
Breathing, MouthMuscle RelaxationPain, Postoperative+1 more
Bitlis Eren University 125
Next Page